The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
Abstract
Background Isolated systolic hypertension occurs in about 15% of people aged 60 years or older. In 1989, the European Working Party on High Blood Pressure in the Elderly investigated whether active treatment could reduce cardiovascular complications of isolated systolic hypertension. Fatal and non-fatal stroke combined was the primary endpoint.Methods All patients (> 60 years) were initially started on masked placebo. At three run-in visits 1 month apart, their average sitting systolic blood pressure was 160-219 mm Hg with a diastolic blood pressure lower than 95 mm Hg. After stratification for centre, sex, and previous cardiovascular complications, 4695 patients were randomly assigned to nitrendipine 10-40 mg daily, with the possible addition of enalapril 5-20 mg daily and hydrochlorothiazide 12.5-25.0 mg daily, or matching placebos. Patients withdrawing from double-blind treatment were still followed up. We compared occurrence of major endpoints by intention to treat.Findings At a median of 2 years' follow-up, sitting systolic and diastolic blood pressures had fallen by 13 mm Hg and 2 mm Hg in the placebo group (n = 2297) and by 23 mm Hg and 7 mm Hg in the active treatment group (n = 2398). The between-group differences were systolic 10.1 mm Hg (95% CI 8.8-11.4) and diastolic, 4.5 mm Hg (3.9-5.1). Active treatment reduced the total rate of stroke from 13.7 to 7.9 endpoints per 1000 patient-years (42% reduction; p = 0.003). Non-fatal stroke decreased by 44% (p = 0.007). In the active treatment group, all fatal and non-fatal cardiac endpoints, including sudden death, declined by 26% (p = 0.03). Non-fatal cardiac endpoints decreased by 33% (p = 0.03) and all fatal and non-fatal cardiovascular endpoints by 31% (p < 0.001). Cardiovascular mortality was slightly lower on active treatment (-27%, p = 0.07), but all-cause mortality was not influenced (-14%; p = 0.22).Interpretation Among elderly patients with isolated systolic hypertension, antihypertensive drug treatment starting with nitrendipine reduces the rate of cardiovascular complications. Treatment of 1000 patients for 5 years with this type of regimen may prevent 29 strokes or 53 major cardiovascular endpoints.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, in a PROGRESS MRI substudy, it was shown that active blood pressure lowering stopped or delayed the progression of white matter hyperintensities.452”
In the citing paper
“Individuals in the top decile compared with the lowest decile had a thirty-fold (men) to seventy-fold (women) difference in the incidence of coronary heart disease.”
From The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective (2014) · cites this paper as [48]
In the citing paper
“The first attempt to create a multivariable risk function for coronary heart disease in Framingham was published by Truett, Cornfield, and Kannel in 1967.48”
From The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective (2014) · cites this paper as [48]
Citations
Cites
(1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440420033005 · Cited by 3,777
A Multiple Testing Procedure for Clinical Trials
O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics · doi:10.2307/2530245 · Cited by 3,311
Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)
Dahlöf, B., Hansson, L., Lindholm, L. H., Scherstén, B., Ekbom, T., & Wester, P.-O. (1991) · The Lancet · doi:10.1016/0140-6736(91)92589-t · Cited by 1,881
(1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410020010002 · Cited by 1,608
AMERY, A. (1985) · The Lancet · doi:10.1016/s0140-6736(85)91783-0 · Cited by 1,476
Self-citationMedical Research Council trial of treatment of hypertension in older adults: principal results.
Peart, S., Brennan, P. J., Broughton, P., Dollery, C. T., Hudson, M. F., Lever, A. F., Meade, T. W., Rose, G., & Pocock, S. (1992) · Cited by 1,360
Self-citation
Cited by
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
Self-citationChobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286
Self-citationJames, P. A., Oparil, S., Carter, B. L., Cushman, W. C., Dennison-Himmelfarb, C., Handler, J., Lackland, D. T., LeFevre, M. L., MacKenzie, T. D., Ogedegbe, O., et al. (2014) · JAMA · doi:10.1001/jama.2013.284427 · Cited by 7,950
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Metadata
- Authors
- Staessen, J. A., Fagard, R., Thijs, L., Celis, H., Arabidze, G. G., Birkenhäger, W. H., Bulpitt, C. J., de Leeuw, P. W., Dollery, C. T., Fletcher, A. E., Forette, F., Leonetti, G., Nachev, C., O' Brien, E. T., Rosenfeld, J., Rodicio, J. L., Tuomilehto, J., & Zanchetti, A.
- Affiliations
- KU Leuven (BE)
- Erasmus University Rotterdam (NL)
- University of London (GB)
- London School of Hygiene & Tropical Medicine (GB)
- Université Paris Cité (FR)
- University of Milan (IT)
- Alexandrovska Hospital (BG)
- Tel Aviv University (IL)
- Hospital Universitario 12 De Octubre (ES)
- Corresponding author
- Staessen, Jan A
- ORCID
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1997-09
- Volume
- 350
- Issue
- 9080
- Pages
- 757-764
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2114634962
- Cited by
- 2,989
- References
- 40
- Citations by year
- 2026: 9 · 2025: 26 · 2024: 27 · 2023: 39 · 2022: 44 · 2021: 56 · 2020: 56 · 2019: 57 · 2018: 91 · 2017: 99 · 2016: 84 · 2015: 80 · 2014: 99 · 2013: 86 · 2012: 107
- FWCI
- 113.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (submittedVersion)
- Funders
- Bayer
- European Commission
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
- Keywords
- isolated systolic hypertension, older adults, antihypertensive therapy, nitrendipine, enalapril, hydrochlorothiazide, stroke prevention, cardiovascular mortality, cardiovascular complications, blood pressure reduction, sudden death, all-cause mortality, hypertension in the elderly, combination antihypertensive therapy
- MeSH terms
- Aged, Antihypertensive Agents, Blood Pressure, Calcium Channel Blockers, Cerebrovascular Disorders, Double-Blind Method, Drug Therapy, Combination, Enalapril, Female, Follow-Up Studies, Humans, Hydrochlorothiazide, Hypertension, Male, Morbidity, Nitrendipine, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. https://app.cochat.ai/papers/10.1016/s0140-6736(97)05381-6
- The paper
- Staessen, J. A., Fagard, R., Thijs, L., Celis, H., Arabidze, G. G., Birkenhäger, W. H., Bulpitt, C. J., de Leeuw, P. W., Dollery, C. T., Fletcher, A. E., Forette, F., Leonetti, G., Nachev, C., O' Brien, E. T., Rosenfeld, J., Rodicio, J. L., Tuomilehto, J., & Zanchetti, A. (1997). Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Lancet. https://doi.org/10.1016/s0140-6736(97)05381-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.